Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.
Farragher, Tracey M
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. [electronic resource] - Annals of the rheumatic diseases Apr 2010 - 689-95 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1468-2060
10.1136/ard.2009.108639 doi
Adult
Aged
Antirheumatic Agents--administration & dosage
Arthritis--drug therapy
Confounding Factors, Epidemiologic
Disease Progression
Drug Administration Schedule
Epidemiologic Methods
Female
Humans
Male
Middle Aged
Prognosis
Time Factors
Treatment Outcome
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. [electronic resource] - Annals of the rheumatic diseases Apr 2010 - 689-95 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1468-2060
10.1136/ard.2009.108639 doi
Adult
Aged
Antirheumatic Agents--administration & dosage
Arthritis--drug therapy
Confounding Factors, Epidemiologic
Disease Progression
Drug Administration Schedule
Epidemiologic Methods
Female
Humans
Male
Middle Aged
Prognosis
Time Factors
Treatment Outcome